Eli Lilly & Co.’s experimental obesity pill helped patients lose 9.6% of their body weight in a trial that moves the company one step closer to a potential approval. Damian Garde has more on “Bloomberg Open Interest.”
www.bloomberg.com
#Eli #Lillys #Obesity #Pill #Moves #Closer #Approval
Silicon Valley’s richest venture capital firm emerges as a “lobbying juggernaut” for minimal AI regulation. www.bloomberg.com #Andreessen #Horowitzs #RisingInfluence #TrumpEra #Policy Related…
Ekrem Imamoglu is expected in court on Wednesday as his CHP party condemns what it calls a widening crackdown on its…
The boom in artificial intelligence stocks is creating a risk of a bubble, which could threaten emerging markets, South Africa’s…
